Cited 0 times in Scipus Cited Count

Transcriptomic profiling of intermediate cell carcinoma of the liver

DC Field Value Language
dc.contributor.authorJang, B-
dc.contributor.authorKwon, SM-
dc.contributor.authorKim, JH-
dc.contributor.authorKim, JM-
dc.contributor.authorChung, T-
dc.contributor.authorYoo, JE-
dc.contributor.authorKim, H-
dc.contributor.authorCalderaro, J-
dc.contributor.authorWoo, HG-
dc.contributor.authorPark, YN-
dc.date.accessioned2024-09-27T00:19:59Z-
dc.date.available2024-09-27T00:19:59Z-
dc.date.issued2024-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/32841-
dc.description.abstractBackground: Intermediate cell carcinoma (Int-CA) is a rare and enigmatic primary liver cancer characterized by uniform tumor cells exhibiting mixed features of both HCC and intrahepatic cholangiocarcinoma. Despite the unique pathological features of int-CA, its molecular characteristics remain unclear yet. Methods: RNA sequencing and whole genome sequencing profiling were performed on int-CA tumors and compared with those of HCC and intrahepatic cholangiocarcinoma. Results: Int-CAs unveiled a distinct and intermediate transcriptomic feature that is strikingly different from both HCC and intrahepatic cholangiocarcinoma. The marked abundance of splicing events leading to intron retention emerged as a signature feature of int-CA, along with a prominent expression of Notch signaling. Further exploration revealed that METTL16 was suppressed within int-CA, showing a DNA copy number–dependent transcriptional deregulation. Notably, experimental investigations confirmed that METTL16 suppression facilitated invasive tumor characteristics through the activation of the Notch signaling cascade. Conclusions: Our results provide a molecular landscape of int-CA featured by METTL16 suppression and frequent intron retention events, which may play pivotal roles in the acquisition of the aggressive phenotype of Int-CA.-
dc.language.isoen-
dc.subject.MESHBile Duct Neoplasms-
dc.subject.MESHCarcinoma, Hepatocellular-
dc.subject.MESHCholangiocarcinoma-
dc.subject.MESHFemale-
dc.subject.MESHGene Expression Profiling-
dc.subject.MESHGene Expression Regulation, Neoplastic-
dc.subject.MESHHumans-
dc.subject.MESHLiver Neoplasms-
dc.subject.MESHMale-
dc.subject.MESHMethyltransferases-
dc.subject.MESHMiddle Aged-
dc.subject.MESHSignal Transduction-
dc.subject.MESHTranscriptome-
dc.titleTranscriptomic profiling of intermediate cell carcinoma of the liver-
dc.typeArticle-
dc.identifier.pmid39101773-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11299988-
dc.contributor.affiliatedAuthorWoo, HG-
dc.type.localJournal Papers-
dc.identifier.doi10.1097/HC9.0000000000000505-
dc.citation.titleHepatology communications-
dc.citation.volume8-
dc.citation.number8-
dc.citation.date2024-
dc.citation.startPagee0505-
dc.citation.endPagee0505-
dc.identifier.bibliographicCitationHepatology communications, 8(8). : e0505-e0505, 2024-
dc.identifier.eissn2471-254X-
dc.relation.journalidJ02471254X-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Physiology
Files in This Item:
39101773.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse